深圳欣博盛生物科技有限公司

Beta-Amyloid 1-42 HFIP treated

Beta amyloid 1-42 is a synthetic peptide widely used in Alzheimer's disease research due to its critical role in plaque formation in the brain. This form, treated with hexafluoroisopropanol (HFIP), ensures disruption of beta-sheets and reduces unwanted secondary structures, making it ideal for consistent experimental outcomes.CAS: 107761-42-2 Synonyms: abeta 1 42, amyloid beta peptide 1-42, amyloid 1 42, amyloid 1-4Synthetic peptide derived from the N-terminal region of human Amyloid beta A4 protein (Swiss-Prot ID: P05067). HFIP treatment is performed to disrupt beta-sheets and other unwanted secondary structures. Beta-Amyloid 1-42 HFIP treated - SpecificationsPeptide Sequence: DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIAProtein Name: Amyloid beta (A4) (alternative names: Abeta, Beta amyloid, APP)Purity: >95% (HPLC-MS)Delivery Format: Freeze-dried in plastic vialCAS: 107761-42-2Application(s): Condition(s)/Topic(s): Alzheimer's diseaseStandard Delivery Time: approx. 3 weeks Applications in Alzheimer Disease ResearchBeta amyloid 1-42 is a crucial component in: Understanding Alzheimer Pathogenesis: Understanding the aggregation of amyloid plaques in neural tissues. Drug Discovery: Screening and testing potential therapeutic agents that target amyloid beta aggregation. Biomarker Development: Identifying early-stage biomarkers for Alzheimer's diagnosis. Its HFIP-treated form provides better reproducibility and structural consistency, making it a preferred choice for in vitro and in vivo studies. Customization for Your Research Needs At JPT Peptide Technologies, we understand that every research project has unique requirements. We offer tailored peptide synthesis services to match your specific needs, whether its beta amyloid 1-42, amyloid beta 1-42, or other variants of amyloid beta peptides. Choose your preferred sequence, amount, and purity, and our expert team will guide you through the process to ensure optimal results. Why Choose JPT Peptide Technologies? With over two decades of peptide synthesis expertise, JPT stands out for quality and precision. Our beta amyloid 1-42 peptides are produced under stringent quality standards at our ISO-certified facility in Berlin.What Sets Us Apart:Custom synthesis with guaranteed purity and sequence verificationHigh-throughput production capacityTrusted partner in clinical and preclinical researchAll peptides provided with HPLC-MS analysis Explore More Peptide Tools for Alzheimer's Research Visit our webpage to explore a wide range of peptide tools designed specifically for Alzheimer's disease research. Whether you need other Abeta peptides, custom modifications, or detailed consultation, we are here to assist you every step of the way.Visit our webpage for more Peptide Tools to Study Alzheimer's DiseaseAre you interested in your other Abeta Peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

德国

JPT Peptide Technologies

>95% (HPLC-MS)